» Articles » PMID: 8048164

Signaling by the Cytokine Receptor Superfamily: JAKs and STATs

Overview
Specialty Biochemistry
Date 1994 May 1
PMID 8048164
Citations 136
Authors
Affiliations
Soon will be listed here.
Abstract

A variety of cytokines, lymphokines and growth factors function by interacting with receptors that are members of the cytokine receptor superfamily. These receptors share extracellular motifs and have limited similarity in their cytoplasmic domains. Although lacking catalytic domains, this family of receptors couples ligand binding with the induction of tyrosine phosphorylation. Recent studies have shown that this is mediated by members of the Janus kinase (JAK) family of cytoplasmic protein tyrosine kinases. JAKs physically associate with the membrane-proximal region of the ligand-bound receptor, leading to their tyrosine phosphorylation and activation. The activated JAKs phosphorylate the receptors as well as cytoplasmic proteins belonging to a family of transcription factors called the signal transducers and activators of transcription (STATs), providing a novel signaling pathway that is shared by all members of the cytokine receptor superfamily.

Citing Articles

The Role and Mechanism of TRIM Proteins in Gastric Cancer.

Wu W, Yang J, Yu T, Zou Z, Huang X Cells. 2025; 13(24.

PMID: 39768197 PMC: 11674240. DOI: 10.3390/cells13242107.


Cancer invasion and anaerobic bacteria: new insights into mechanisms.

Hurst R, Brewer D, Gihawi A, Wain J, Cooper C J Med Microbiol. 2024; 73(3).

PMID: 38535967 PMC: 10995961. DOI: 10.1099/jmm.0.001817.


Janus Kinase 3 phosphorylation and the JAK/STAT pathway are positively modulated by follicle-stimulating hormone (FSH) in bovine granulosa cells.

Zareifard A, Beaudry F, Ndiaye K BMC Mol Cell Biol. 2023; 24(1):21.

PMID: 37337185 PMC: 10280845. DOI: 10.1186/s12860-023-00482-5.


Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer.

Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q Signal Transduct Target Ther. 2023; 8(1):204.

PMID: 37208335 PMC: 10196327. DOI: 10.1038/s41392-023-01468-7.


Protein Profiling of Breast Carcinomas Reveals Expression of Immune-Suppressive Factors and Signatures Relevant for Patient Outcome.

Ruoff F, Kersten N, Anderle N, Jerbi S, Stahl A, Koch A Cancers (Basel). 2022; 14(18).

PMID: 36139700 PMC: 9496820. DOI: 10.3390/cancers14184542.